A page on LabLog, a review site (not the lab's official page)
Cancer Immunology Lab
Machine-translated · View original
A lab developing cancer immunotherapy that targets WT1.

AboutAbout the lab
Developing evidence-based cancer immunotherapy
The Endowed Chair of Cancer Immunology pursues basic and clinical research toward new cancer immunotherapies that are gentle on the body and have few side effects.
Centered on the WT1 peptide vaccine, which targets the cancer antigen WT1, the lab investigates ways to enhance the vaccine's effect and its potential as a preventive vaccine.
The lab conducts its research in collaboration with other related departments, many clinicians, and researchers overseas.
It is an endowed chair at the Borderless Design Medical Research Center, Division of Health Sciences, Graduate School of Medicine, Osaka University.
Key terms
- WT1
- The antigen this lab identified as a cancer antigen. It is expressed universally in cancers and is essential for cancer development
- WT1 peptide vaccine
- A treatment that uses the cancer antigen WT1 as a marker to attack only cancer cells, with few side effects
- Preventive vaccine
- A vaccine given preventively before a person develops cancer. The current therapeutic vaccines are given to patients who have been diagnosed with cancer
ResearchResearch themes
The lab aims to develop treatments that attack only cancer cells and cause few side effects, by targeting the cancer antigen WT1, which is expressed universally in cancers. Its work spans mouse model studies through clinical trials, and covers preventive vaccines as well as therapeutic vaccines.
*Illustrative imageWT1, a promising cancer antigen
Cancer immunotherapy became widely known with the advent of immune checkpoint inhibitor therapy in the 2010s. WT1, which this lab identified as a cancer antigen, is expressed universally in cancers and is an antigen essential for cancer development.
*Illustrative imageMethods to enhance vaccine efficacy
Using mouse models, the lab develops strategies to enhance vaccine efficacy, such as combination with adjuvants, chemotherapeutic agents, molecularly targeted drugs, and helper peptides, and has already conducted clinical trials. It also analyzes samples from treated patients in detail.
From therapeutic vaccines to preventive vaccines
Because WT1 is also expressed in cancer stem cells and precancerous lesions, it is promising as a target for preventive vaccines, in addition to the current therapeutic vaccines given to patients diagnosed with cancer. The lab has found efficacy in mice and is advancing clinical trials in humans.
MembersFaculty
- Professor, Endowed ChairHaruo Sugiyama
- Associate Professor, Endowed ChairHiroko Nakajima
VoicesStudent voices
Ratings and reviews reflect the experiences of individual current or former students, not the lab's official views. Whether a lab has reviews, or how many, says nothing about the lab itself.
Students who take part in an interview may receive a thank-you gift worth ¥1,000, regardless of what they say.
Student ratings (0 students)
--
--
--
--
--
--
Student voices answer questions like these
- What's great about this lab?
- What did you learn after joining?
- What's the vibe, and what is the professor like?
- Who is this lab for?
- Where do graduates go?
Your experience can help younger students choose their lab. Your name won't be shown.
Write a lab reviewAnonymous · Your draft is saved if you stopRelatedLabs similar to Cancer Immunology Lab
Cancer Stem Cell Regulation LabGraduate School of Medicine, Department of Health Sciences
Healthcare Economics and Management LabGraduate School of Medicine, Department of Health Sciences
Future Medicine LabGraduate School of Medicine, Department of Health Sciences
Beyond Cell Reborn LabGraduate School of Medicine, Department of Health SciencesThe information on this page is compiled by the LabLog team from the lab's public information and interviews. For corrections or removal requests, please contact LabLog, not the lab.
Report an errorAbout the images
The top and research theme images are illustrative and were not taken at the lab. They are cropped from Wikimedia Commons images. Cropped CC BY-SA images are provided under the same CC BY-SA license as the original (version shown on each line).
- Top image: “Laboratory (3)” Linda Bartlett (Potographer) / Public domain (cropped)
- WT1, a promising cancer antigen: “Processing of tumor antigens recognized by CD8+ T cells” UCLLICRBRU / CC BY-SA 4.0 (cropped)
- Methods to enhance vaccine efficacy: “Syringe, Vaccine Bottle, and Globe ( )” NIAID / CC BY 2.0 (cropped)
- Related lab (癌幹細胞制御学): “T cells in a squamous cell carcinoma” NIH Image Gallery / Public domain (cropped)
- Related lab (医療経済・経営学): “Hospital Reception in Lagos” Beendy234 / CC0 (cropped)
- Related lab (未来医療学): “Stem-cells-vial-ama-regenerative-medicine” [<a href="https://www.amaskincare.com/about/alice-pien-md-medical-director/">Alice Pien, MD</a>] / CC BY-SA 4.0 (cropped)
- Related lab (Beyond Cell Reborn学): “Cell-universe” Bibeh100 / CC BY-SA 4.0 (cropped)
About LabLog
LabLog is a lab review app for students only. Student members at each university interview students in labs and publish what they say. Student voices can only be read by students who sign up with a university email address. Operated by bestiee Inc.
Learn more about LabLog ↗Search engines and AI may reference the basic lab info and rating summaries on this page and the description of LabLog. Student voices are for student members only. Automated collection by programs (scraping, or input to or training of AI) is prohibited under Article 8 of the Terms of Service. If you need data for research or analysis, please contact us.